Rexahn Pharmaceuticals (RNN)
Rexahn Pharmaceuticals Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 10.05M | 11.81M | 15.17M | 18.08M | 22.96M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Inventory | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Prepaid Expenses | 0.2873M | 0.3332M | 0.4557M | 0.4861M | 0.7251M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 10.35M | 12.16M | 15.65M | 18.59M | 23.72M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | 0.6654M | 0.6654M | 0.6537M | 0.6515M | 0.6493M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accumulated Depreciation | 0.5816M | 0.5708M | 0.5607M | 0.5505M | 0.5399M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Property, Plant & Equipment | 0.0838M | 0.0945M | 0.0931M | 0.1009M | 0.1094M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Assets | 1.276M | 1.432M | 2.948M | 3.178M | 3.360M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 1.360M | 1.526M | 3.040M | 3.284M | 3.481M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 11.71M | 13.69M | 18.69M | 21.88M | 27.20M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 1.02M | 1.185M | 3.906M | 3.892M | 2.940M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Deferred Revenues | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 1.02M | 1.185M | 3.906M | 3.892M | 2.940M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | 1.226M | 0.9731M | 3.767M | 5.643M | 6.243M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Liabilities | 2.032M | 1.798M | 4.611M | 6.505M | 7.124M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 3.052M | 2.984M | 8.517M | 10.40M | 10.06M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 95.35M | 95.35M | 95.27M | 95.24M | 95.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.0095M | 0.0095M | 0.0095M | 0.0095M | 0.0095M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 67.90M | 67.81M | 67.67M | 67.50M | 67.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -59.22M | -57.08M | -57.47M | -56.00M | -50.18M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | 0.0284M | 0.0284M | 0.0284M | 0.0284M | 0.0284M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 8.658M | 10.71M | 10.17M | 11.48M | 17.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 11.71M | 13.69M | 18.69M | 21.88M | 27.20M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |